
<!DOCTYPE html><HTML><HEAD>
<META HTTP-EQUIV="X-UA-Compatible" CONTENT="IE=EDGE" />
<LINK rel="stylesheet" href="CRStyleSheet.css"></LINK>
</HEAD>
<body id="theBody">
<div id="oContextHTML" style="display: none;"></div>
<div id="oContent">
<table class="Header2"><tbody><tr><td>DOCS_RCVD_CANCER_STAGES</td></tr></tbody></table>
<table class="KeyValue"><tbody>
<tr>
<td width="10%" align="left" class="T1Head">Description: </td>
<td class="T1Value" colspan="5">
<table class="SubList"><tbody>
<tr>
<td class="T1Value" style="white-space: normal;">This table stores cancer stages received from outside sources.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<br/>
<table class="SubHeader3"><tbody><tr><td>Primary Key</td></tr></tbody></table>
<table class="List"><tbody>
<tr>
<th>Column Name</th>
<th>Ordinal Position</th>
<th width="90%"/>
</tr>
<tr onmouseover="this.bgColor = '#FFFFD1'" onmouseout="this.bgColor='#FFFFFF'">
<td>DOCUMENT_ID</td>
<td>1</td>
<td width="90%"/>
</tr>
<tr onmouseover="this.bgColor = '#FFFFD1'" onmouseout="this.bgColor='#FFFFFF'">
<td>CONTACT_DATE_REAL</td>
<td>2</td>
<td width="90%"/>
</tr>
<tr onmouseover="this.bgColor = '#FFFFD1'" onmouseout="this.bgColor='#FFFFFF'">
<td>LINE</td>
<td>3</td>
<td width="90%"/>
</tr>
</tbody></table>
<br/>
<table class="SubHeader3"><tbody><tr><td>Column Information</td></tr></tbody></table>
<table class="SubList List"><tbody>
<tr>
<th style="min-width: 0px;"/>
<th>Name</th>
<th>Type</th>
<th>Discontinued?</th>
<th width="90%"/>
</tr>
<tr>
<td class="T1Head" style="padding: 5px;">1</td>
<td class="T1Head" style="padding-right: 12px;">DOCUMENT_ID</td>
<td class="T1Head" style="padding-right: 12px;">NUMERIC</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> The unique identifier (.1 item) for the document record.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">2</td>
<td class="T1Head" style="padding-right: 12px;">CONTACT_DATE_REAL</td>
<td class="T1Head" style="padding-right: 12px;">FLOAT</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> A unique contact date in decimal format. The integer portion of the number indicates the date of contact. The digits after the decimal distinguish different contacts on the same date and are unique for each contact on that date. For example, .00 is the first/only contact, .01 is the second contact, etc.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">3</td>
<td class="T1Head" style="padding-right: 12px;">LINE</td>
<td class="T1Head" style="padding-right: 12px;">INTEGER</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> The line number for the information associated with this contact. Multiple pieces of information can be associated with this contact.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">4</td>
<td class="T1Head" style="padding-right: 12px;">HISTOPATHOLOGIC_TYPE_C_NAME</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> This column stores the histopathologic type associated with the cancer stage.</td>
</tr>
<tr>
<td>May contain organization-specific values: Yes</td>
</tr>
<tr>
<td> Category Entries: </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neoplasm, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neoplasm, uncertain whether benign or malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neoplasm, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neoplasm, metastatic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neoplasm, malignant, uncertain whether primary or metastatic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tumor cells, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tumor cells, uncertain whether benign or malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tumor cells, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant tumor, small cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant tumor, giant cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant tumor, spindle cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant tumor, clear cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelial tumor, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma in situ, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma, metastatic, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinomatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Large cell carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Large cell neuroendocrine carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Large cell carcinoma with rhabdoid phenotype</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glassy cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma, undifferentiated, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma, anaplastic, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pleomorphic carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nuclear protein in testis (NUT) associated carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Giant cell and spindle cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Giant cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pseudosarcomatous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Polygonal cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma with osteoclast-like giant cells</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tumorlet, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tumorlet, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Small cell carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Oat cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Small cell carcinoma, fusiform cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Small cell carcinoma, intermediate cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Combined small cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Non-small cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papilloma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary carcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Verrucous papilloma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Verrucous carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell papilloma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary squamous cell carcinoma, non-invasive</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary squamous cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell papilloma, inverted</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Warty dyskeratoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Warty carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous papillomatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Actinic keratosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma in situ, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, metastatic, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Differentiated intraepithelial neoplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, keratinizing, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Large cell acanthoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, large cell, nonkeratinizing, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, small cell, nonkeratinizing</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, spindle cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, adenoid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma in situ with questionable stromal invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, microinvasive</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous intraepithelial neoplasia, low grade</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous intraepithelial neoplasia, high grade</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma with horn formation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Queyrat erythroplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bowen disease</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphoepithelial carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basaloid squamous cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell acanthoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, clear cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, HPV-positive</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, HPV-negative</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basal cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basal cell carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Superficial basal cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Infiltrating basal cell carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basal cell carcinoma, fibroepithelial</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basosquamous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Metatypical carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraepidermal epithelioma of Jadassohn</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basal cell carcinoma, nodular</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenoid basal carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Trichoepithelioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Trichoblastic carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Trichofolliculoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Trichilemmoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Trichilemmocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pilar tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Proliferating trichilemmal cyst</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pilar sheath acanthoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pilomatricoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pilomatrical carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Urothelial papilloma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Urothelial carcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Transitional cell carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sinonasal papilloma, exophytic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sinonasal papilloma, inverted</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Schneiderian carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Urothelial carcinoma, sarcomatoid </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basaloid carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cloacogenic carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary urothelial neoplasm of low malignant potential</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary urothelial carcinoma, non-invasive</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary transitional cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Urothelial carcinoma, micropapillary</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in situ, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, metastatic, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Scirrhous adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Linitis plastica</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Superficial spreading adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenoma, intestinal type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, intestinal type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma, diffuse type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Monomorphic adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basal cell adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basal cell adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glandular intraepithelial neoplasia, low grade</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glandular intraepithelial neoplasia, high grade</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Canalicular adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pancreatic neuroendocrine microadenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pancreatic neuroendocrine tumor, nonfunctioning</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Insulinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glucagonoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gastrinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Vipoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Somatostatinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">ACTH-producing tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bile duct adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cholangiocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bile duct cystadenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bile duct cystadenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Klatskin tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pancreatobiliary neoplasm, non-invasive</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary neoplasm, pancreatobiliary type, with high grade intraepithelial neoplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pancreatobiliary type carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Liver cell adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatocellular carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatocellular carcinoma, fibrolamellar</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatocellular carcinoma, scirrhous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatocellular carcinoma, spindle cell variant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatocellular carcinoma, clear cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatocellular carcinoma, pleomorphic type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Combined hepatocellular carcinoma and cholangiocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Trabecular adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Trabecular adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Embryonal adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Eccrine dermal cylindroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenoid cystic carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cribriform carcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cribriform carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Microcystic adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lactating adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenomatous polyp, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in situ in adenomatous polyp</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in adenomatous polyp</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tubular adenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tubular adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Flat adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serrated adenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serrated adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Parietal cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma of anal glands</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenomatous polyposis coli</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in adenomatous polyposis coli</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Multiple adenomatous polyps</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in multiple adenomatous polyps</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ductal carcinoma in situ, solid type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Solid carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma simplex</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neuroendocrine tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Enterochromaffin cell carcinoid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Enterochromaffin-like cell tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Goblet cell carcinoid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed adenoneuroendocrine carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tubular carcinoid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoid tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neuroendocrine carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Merkel cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Apudoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neuroendocrine tumor, grade 2</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical adenomatous hyperplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pulmonary adenomatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in situ of the lung, non-mucinous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lepidic adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Alveolar adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Alveolar adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bronchiolo-alveolar carcinoma, non-mucinous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in situ of the lung, mucinous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma of the lung, mucinous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma of the lung, mixed mucinous and non-mucinous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma with mixed subtypes</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Minimally invasive adenocarcinoma, non-mucinous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Minimally invasive adenocarcinoma, mucinous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary adenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Aggressive papillary tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary adenocarcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Villous adenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in situ in villous adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in villous adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Villous adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tubulovillous adenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in situ in tubulovillous adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in tubulovillous adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillomatosis, glandular</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Micropapillary carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chromophobe adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chromophobe carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lactotroph adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pituitary adenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pituitary carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pituitary blastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acidophil adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acidophil carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed acidophil-basophil adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed acidophil-basophil carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Oxyphilic adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Oxyphilic adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basophil adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basophil carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell adenocarcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hypernephroid tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hereditary leiomyomatosis and renal cell carcinoma (HRCC)-associated renal cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Renal cell carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell adenofibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell borderline tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell adenocarcinofibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lipid-rich carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glycogen-rich carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Multilocular cystic renal neoplasm of low malignant potential </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cyst-associated renal cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Renal cell carcinoma, chromophobe type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Renal cell carcinoma, sarcomatoid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Collecting duct carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Granular cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chief cell adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Water-clear cell adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Water-clear cell adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed cell adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell papillary renal cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed cell adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lipoadenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Metanephric adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular adenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical follicular adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular adenocarcinoma, well differentiated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular adenocarcinoma, trabecular</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Microfollicular adenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fetal adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Macrofollicular adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular tumor of uncertain malignant potential</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular carcinoma, minimally invasive</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hyalinizing trabecular tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Poorly differentiated thyroid carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular carcinoma, encapsulated, angioinvasive</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary carcinoma, follicular variant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary microcarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary carcinoma, oncocytic variant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary carcinoma, encapsulated of thyroid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary carcinoma, columnar cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medullary thyroid carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed medullary-follicular carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed medullary-papillary carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Well differentiated tumor of uncertain malignant potential</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nonencapsulated sclerosing carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Multiple endocrine adenomas</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Juxtaglomerular tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adrenal cortical adenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adrenal cortical carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adrenal cortical adenoma, compact cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adrenal cortical adenoma, pigmented</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adrenal cortical adenoma, clear cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adrenal cortical adenoma, glomerulosa cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adrenal cortical adenoma, mixed cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid adenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid adenoma, borderline malignancy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid intraepithelial neoplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid adenocarcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid adenofibroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid adenofibroma, borderline malignancy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid adenofibroma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid adenocarcinoma, secretory variant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid adenocarcinoma, ciliated cell variant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, endocervical type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Skin appendage adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adnexal adenocarcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular fibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Syringofibroadenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sweat gland adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sweat gland tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sweat gland adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Apocrine adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Apocrine adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hidradenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hidradenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spiradenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant eccrine spiradenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hidrocystoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary hidradenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Syringocystadenoma papilliferum</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Syringocystadenocarcinoma papilliferum</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Syringoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Microcystic adnexal carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Eccrine papillary adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Digital papillary adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Poroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Porocarcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Porocarcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sebaceoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sebaceous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Eccrine adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ceruminous adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ceruminous adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucoepidermoid tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucoepidermoid carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cystadenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cystadenocarcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous cystadenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous intraepithelial carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous borderline tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell cystadenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary cystadenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary cystadenocarcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary cystadenoma, borderline malignancy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Solid pseudopapillary tumor of ovary</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Solid pseudopapillary neoplasm of the pancreas</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraductal Papillary mucinous adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraductal Papillary mucinous neoplasm with high grade dysplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraductal Papillary mucinous neoplasm with an associated invasive carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cystic tumor of atrio-ventricular node</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous borderline tumor, micropapillary variant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Low grade serous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous surface papilloma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">High grade serous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous cystadenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous cystic neoplasm with high grade dysplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous cystadenocarcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous cystic tumor of borderline malignancy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Seromucinous cystadenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Seromucinous borderline tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Seromucinous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Low grade appendiceal mucinous neoplasm</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pseudomyxoma peritonei</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucin-producing adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous carcinoma, gastric type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Signet ring cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Metastatic signet ring cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraductal carcinoma, noninfiltrating, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Infiltrating duct carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Comedocarcinoma, noninfiltrating</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Comedocarcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Secretory carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraductal papilloma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Noninfiltrating intraductal papillary adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraductal papillary adenocarcinoma with invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intracystic papillary adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Encapsulated papillary carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Encapsulated papillary carcinoma with invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraductal papillomatosis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenoma of nipple</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraductal micropapillary carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Invasive micropapillary carcinoma of breast</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cystic hypersecretory carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Solid papillary carcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Solid papillary carcinoma with invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medullary carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medullary carcinoma with lymphoid stroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical medullary carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Duct carcinoma, desmoplastic type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lobular carcinoma in situ, pleomorphic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lobular carcinoma in situ, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lobular carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Infiltrating ductular carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraductal carcinoma and lobular carcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Infiltrating duct and lobular carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Infiltrating duct mixed with other types of carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Infiltrating lobular mixed with other types of carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Polymorphous adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Inflammatory carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paget disease, mammary</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paget disease and infiltrating duct carcinoma of breast</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paget disease, extramammary</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paget disease and intraductal carcinoma of breast</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acinar cell adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acinar cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acinar cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acinar cell cystadenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed acinar-ductal carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed squamous cell and glandular papilloma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenosquamous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenolymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelial-myoepithelial carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphadenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma with squamous metaplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma with cartilaginous and osseous metaplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma with spindle cell metaplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma with apocrine metaplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma with neuroendocrine differentiation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Metaplastic carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatoid adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Microscopic thymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Micronodular thymoma with lymphoid stroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, type A</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, type AB</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, type B1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, type B2</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, type B3</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymic carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ectopic hamartomatous thymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle epithelial tumor with thymus-like element</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intrathyroid thymic carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sex cord-stromal tumor, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sex cord-gonadal stromal tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sex cord-gonadal stromal tumor, incompletely differentiated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sex cord-gonadal stromal tumor, mixed forms</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Stromal tumor with minor sex cord elements</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed germ cell-sex cord-stromal tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thecoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thecoma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thecoma, luteinized</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sclerosing stromal tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Luteoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adult granulosa cell tumor of testis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adult granulosa cell tumor of ovary</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Granulosa cell-theca cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Granulosa cell tumor of the testis, juvenile</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Granulosa cell tumor, juvenile</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sex cord tumor with annular tubules</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Androblastoma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Androblastoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Androblastoma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sertoli-Leydig cell tumor, well differentiated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sertoli-Leydig cell tumor of intermediate differentiation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sertoli-Leydig cell tumor, poorly differentiated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gynandroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sertoli-Leydig cell tumor, retiform</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sertoli cell tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sertoli cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sertoli cell tumor with lipid storage</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Large cell calcifying Sertoli cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intratubular large cell hyalinizing Sertoli cell neoplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Leydig cell tumor of the ovary, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Leydig cell tumor of the testis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Leydig cell tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hilus cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lipid cell tumor of ovary</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Steroid cell tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adrenal rest tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paraganglioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sympathetic paraganglioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Parasympathetic paraganglioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gangliocytic paraganglioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Middle ear paraganglioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Aortic body tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carotid body paraganglioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Extra-adrenal paraganglioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pheochromocytoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glomangiosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glomus tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glomangiomatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glomus tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glomangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glomangiomyoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Perivascular epithelioid tumor, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Perivascular epithelioid tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pigmented nevus, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Melanoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant melanoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nodular melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Balloon cell nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Balloon cell melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Halo nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant melanoma, regressing</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neuronevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Magnocellular nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dysplastic nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Meningeal melanocytosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Meningeal melanocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Meningeal melanomatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nonpigmented nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Amelanotic melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Junctional nevus, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant melanoma in junctional nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Precancerous melanosis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant melanoma in precancerous melanosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lentiginous melanocytic nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lentigo maligna</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lentigo maligna melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Low cumulative sun damage melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acral nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acral melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Desmoplastic melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucosal lentiginous melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dermal nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Compound nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Congenital melanocytic nevus, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Giant pigmented nevus, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant melanoma arising in giant congenital nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Proliferative dermal lesion in congenital nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid and spindle cell nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant Spitz tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid cell nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid cell melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell nevus, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell melanoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell melanoma, type A</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell melanoma, type B</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Blue nevus, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pigmented epithelioid melanocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Blue nevus, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cellular blue nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Soft tissue tumor, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sarcomatosis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pleomorphic hyalinizing angiectatic tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Giant cell sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Small cell sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Undifferentiated sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Desmoplastic small round cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cellular fibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibrosarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibromyxoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myxoinflammatory fibroblastic sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myxofibrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Periosteal fibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Periosteal fibrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibroma of tendon sheath</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Palmar/plantar type fibromatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fascial fibrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Infantile fibrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Solitary fibrous tumor/Hemangiopericytoma, grade 1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Solitary fibrous tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Solitary fibrous tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Calcifying aponeurotic fibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Calcifying fibrous tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibrous dysplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Elastofibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Aggressive fibromatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Abdominal fibromatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sclerotic fibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Desmoplastic fibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myofibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myofibromatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myofibroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myofibroblastic tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myofibroblastic sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiomyofibroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myofibroblastic tumor, peribronchial</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nodular fasciitis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Benign fibrous histiocytoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical fibrous histiocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant fibrous histiocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Histiocytoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dermatofibroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dermatofibrosarcoma protuberans, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dermatofibrosarcoma protuberans, fibrosarcomatous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pigmented dermatofibrosarcoma protuberans</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Giant cell fibroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Plexiform fibrohistiocytic tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiomatoid fibrous histiocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myxoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myxosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiomyxoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ossifying fibromyxoid tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ossifying fibromyxoid tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lipoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical lipomatous tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Liposarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibrolipoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lipofibromatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Liposarcoma, well differentiated, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibromyxolipoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myxoid liposarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Round cell liposarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pleomorphic lipoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pleomorphic liposarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed liposarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intramuscular lipoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell lipoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibroblastic liposarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dedifferentiated liposarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiomyolipoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiomyolipoma, epithelioid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiolipoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chondroid lipoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myelolipoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hibernoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lipoblastomatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Leiomyoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Leiomyomatosis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Leiomyosarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid leiomyoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid leiomyosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cellular leiomyoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bizarre leiomyoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angioleiomyoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiomyosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myxoid leiomyoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myxoid leiomyosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Smooth muscle tumor of uncertain malignant potential</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Metastasizing leiomyoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Rhabdomyoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Rhabdomyosarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pleomorphic rhabdomyosarcoma, adult type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed type rhabdomyosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fetal rhabdomyoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adult cellular rhabdomyoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Genital rhabdomyoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Embryonal rhabdomyosarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell rhabdomyosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Alveolar rhabdomyosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ectomesenchymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrial stromal nodule</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrial stromal sarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrial stromal sarcoma, low grade</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenomyoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinofibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Stromal tumor, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Stromal tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Stromal sarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gastrointestinal stromal tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pleomorphic adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed tumor, malignant, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma ex pleomorphic adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mullerian mixed tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesodermal mixed tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Benign cystic nephroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cystic partially differentiated nephroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant cystic nephroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesoblastic nephroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nephroblastoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Rhabdoid tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell sarcoma of kidney</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Renomedullary interstitial cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ossifying renal tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatoblastoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pancreatoblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pulmonary blastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pleuropulmonary blastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sialoblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Calcifying nested stromal-epithelial tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinosarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinosarcoma, embryonal</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myoepithelioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myoepithelial carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenomyoepithelioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenomyoepithelioma with carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesenchymoma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesenchymoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesenchymoma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Embryonal sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pulmonary hamartoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Brenner tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Brenner tumor, borderline malignancy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Brenner tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibroadenoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intracanalicular fibroadenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pericanalicular fibroadenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenofibroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous adenofibroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous adenofibroma of borderline malignancy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous adenocarcinofibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous adenofibroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous adenofibroma of borderline malignancy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous adenocarcinofibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Giant fibroadenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Phyllodes tumor, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Phyllodes tumor, borderline</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Phyllodes tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Juvenile fibroadenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Synovioma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Synovial sarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Synovial sarcoma, spindle cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Synovial sarcoma, epithelioid cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Synovial sarcoma, biphasic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell sarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Biphenotypic sinonasal sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesothelioma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesothelioma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibrous mesothelioma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibrous mesothelioma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid mesothelioma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Well differentiated papillary mesothelioma of the pleura</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid mesothelioma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesothelioma, biphasic, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenomatoid tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Peritoneal inclusion cysts</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dysgerminoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Seminoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Seminoma, anaplastic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spermatocytic seminoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intratubular malignant germ cells</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Germinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Germ cell tumor, nonseminomatous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Embryonal carcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Yolk sac tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Polyembryoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gonadoblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Teratoma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Teratoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Teratoma, malignant, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Teratocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant teratoma, undifferentiated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant teratoma, intermediate</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dermoid cyst, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Teratoma with malignant transformation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed germ cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Germ cell tumor with associated hematological malignancy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Struma ovarii, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Struma ovarii, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Strumal carcinoid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hydatidiform mole, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Invasive hydatidiform mole</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Choriocarcinoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Choriocarcinoma combined with other germ cell elements</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant teratoma, trophoblastic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Partial hydatidiform mole</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Placental site trophoblastic tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Trophoblastic tumor, epithelioid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenoma of rete ovarii</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Wolffian tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesonephroma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hemangioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hemangiosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cavernous hemangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Venous hemangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Racemose hemangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Kupffer cell sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid hemangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical vascular lesion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hemangioendothelioma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hemangioendothelioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hemangioendothelioma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Capillary hemangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intramuscular hemangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid hemangioendothelioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary intralymphatic angioendothelioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell hemangioendothelioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myointimoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intimal sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Kaposi sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiokeratoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Verrucous keratotic hemangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiofibroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acquired tufted hemangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hemangioblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphangioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphangiosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Capillary lymphangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cavernous lymphangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cystic lymphangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphangiomyoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphangioleiomyomatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hemolymphangioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Osteoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Osteosarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chondroblastic osteosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibroblastic osteosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Telangiectatic osteosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Osteosarcoma in Paget disease of bone</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Small cell osteosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Central osteosarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Low grade central osteosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Osteoid osteoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Parosteal osteosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Periosteal osteosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">High grade surface osteosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intracortical osteosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Osteoblastoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Aggressive osteoblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Osteochondroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Osteochondromatosis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Osteochondromyxoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bizarre parosteal osteochondromatous proliferation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Subungual exostosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chondroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chondromatosis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chondrosarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Periosteal chondroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Periosteal chondrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical cartilaginous tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chondroblastoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chondroblastoma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myxoid chondrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesenchymal chondrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chondromyxoid fibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell chondrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dedifferentiated chondrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Giant cell tumor of bone, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Giant cell tumor of bone, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Giant cell tumor of soft parts, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant giant cell tumor of soft parts</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tenosynovial giant cell tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tenosynovial giant cell tumor, diffuse</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant tenosynovial giant cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Aneurysmal bone cyst</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adamantinoma of long bones</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ossifying fibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Odontogenic tumor, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Odontogenic tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Odontogenic tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ameloblastic fibrodentinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cementoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cementoblastoma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cemento-ossifying fibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gigantiform cementoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Odontoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Compound odontoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Complex odontoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ameloblastic fibro-odontoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ameloblastic odontosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenomatoid odontogenic tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Calcifying odontogenic cyst</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dentinogenic ghost cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ghost cell odontogenic carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ameloblastoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ameloblastoma, metastasizing</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Odontoameloblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous odontogenic tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Odontogenic myxoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Odontogenic fibroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Peripheral odontogenic fibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ameloblastic fibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ameloblastic fibrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Calcifying epithelial odontogenic tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell odontogenic carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Odontogenic carcinosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Craniopharyngioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Craniopharyngioma, adamantinomatous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Craniopharyngioma, papillary</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pinealoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pineocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pineoblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Melanotic neuroectodermal tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ewing sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Askin tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Benign notochordal tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chordoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chondroid chordoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dedifferentiated chordoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Parachordoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glioma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gliomatosis cerebri</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Oligoastrocytoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Subependymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Subependymal giant cell astrocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Diffuse midline glioma, H3 K27M-mutant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Choroid plexus papilloma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical choroid plexus papilloma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Choroid plexus carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sellar ependymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ependymoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ependymoma, anaplastic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary ependymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myxopapillary ependymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary tumor of the pineal region</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ependymoma, RELA fusion-positive</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Astrocytoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Astrocytoma, anaplastic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Protoplasmic astrocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gemistocytic astrocytoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Desmoplastic infantile astrocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dysembryoplastic neuroepithelial tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibrillary astrocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pilocytic astrocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Polar spongioblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pleomorphic xanthoastrocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pilomyxoid astrocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Astroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiocentric glioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pituicytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glioblastoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Giant cell glioblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gliofibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gliosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chordoid glioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glioblastoma, IDH-mutant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Oligodendroglioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Oligodendroglioma, anaplastic, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Oligodendroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medulloblastoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Desmoplastic nodular medulloblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medullomyoblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">CNS embryonal tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Large cell medulloblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medullobloastoma, WNT-activated, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medulloblastoma, SHH-activated and TP53-mutant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medulloblastoma, non-WNT/non-SHH</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Embryonal tumor with multilayered rosettes with C19MC alteration</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cerebellar sarcoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ganglioneuroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ganglioneuroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ganglioneuromatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gangliocytoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neuroblastoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medulloepithelioma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medulloepithelioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Teratoid medulloepithelioma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Teratoid medulloepithelioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neuroepithelioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spongioneuroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ganglioglioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ganglioglioma, anaplastic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Central neurocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pacinian tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical teratoid/rhabdoid tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary glioneuronal tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Retinocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Retinoblastoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Retinoblastoma, differentiated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Retinoblastoma, undifferentiated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Retinoblastoma, diffuse</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Retinoblastoma, spontaneously regressed</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Olfactory neurogenic tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Olfactory neurocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Olfactory neuroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Olfactory neuroepithelioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Meningioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Meningioma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Meningothelial meningioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibrous meningioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Psammomatous meningioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiomatous meningioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hemangioblastic meningioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Transitional meningioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell meningioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary meningioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical meningioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Meningeal sarcomatosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neurofibroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant peripheral nerve sheath tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Melanotic neurofibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant peripheral nerve sheath tumor, epithelioid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Plexiform neurofibroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Schwannoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Melanotic schwannoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neurilemoma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nerve sheath myxoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nerve sheath tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neuroma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Perineurioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Perineurioma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Granular cell tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Granular cell tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Alveolar soft part sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Granular cell tumor of the sellar region</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant lymphoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Monoclonal B-cell lymphocytosis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant lymphoma, non-Hodgkin, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Composite Hodgkin and non-Hodgkin lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary cutaneous follicle centre lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, lymphocyte-rich</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, mixed cellularity, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, lymphocyte depletion, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, lymphocyte depletion, reticular</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, nodular lymphocyte predominant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin granuloma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, nodular sclerosis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, nodular sclerosis, cellular phase</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, nodular sclerosis, grade 1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, nodular sclerosis, grade 2</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphoplasmacytic lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">In situ mantle cell neoplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mantle cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant lymphoma, mixed small and large cell, diffuse</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary effusion lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mediastinal large B-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">EBV positive mucocutaneous ulcer</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Diffuse large B-cell lymphoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Burkitt lymphoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">T-cell/histiocyte rich large B-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Splenic marginal zone B-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular lymphoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular lymphoma, grade 2</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">In situ follicular neoplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular lymphoma, grade 1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular lymphoma, grade 3</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Marginal zone B-cell lymphoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mycosis fungoides</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sezary syndrome</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mature T-cell lymphoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angioimmunoblastic T-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Subcutaneous panniculitis-like T-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cutaneous T-cell lymphoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intravascular large B-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Anaplastic large cell lymphoma, T-cell and Null-cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Anaplastic large cell lymphoma, ALK negative</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatosplenic T-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intestinal T-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary cutaneous CD30+T-cell lymphoproliferative disorder</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary cutaneous anaplastic large cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">NK/T-cell lymphoma, nasal and nasal type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Systemic EBV positive T-cell lymphoproliferative disease of childhood</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hydroa vacciniforme-like lymphoproliferative disorder</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary cutaneous gamma-delta T-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Precursor cell lymphoblastic lymphoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Plasmacytoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Plasma cell myeloma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Plasma cell leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Plasmacytoma, extramedullary</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Plasmablastic lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">ALK positive large B-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">HHV8-positive diffuse large B-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mastocytoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mast cell sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Indolent systemic mastocytosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant mastocytosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mast cell leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Erdheim-Chester disease</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant histiocytosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Langerhans cell histiocytosis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Langerhans cell histiocytosis, disseminated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Histiocytic sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Langerhans cell sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Interdigitating dendritic cell sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular dendritic cell sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibroblastic reticular cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Immunoproliferative disease, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">IgM monoclonal gammopathy of undetermined significance</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Waldenstrom macroglobulinemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Heavy chain disease, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Immunoproliferative small intestinal disease</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Monoclonal gammopathy of undetermined significance, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiocentric immunoproliferative lesion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphomatoid granulomatosis, grade 3</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angioimmunoblastic lymphadenopathy (AIL)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">T-gamma lymphoproliferative disease</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Immunoglobulin deposition disease</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute biphenotypic leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed phenotype acute leukemia, B/myeloid, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed phenotype acute leukemia, T/myeloid, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">B lymphoblastic leukemia/lymphoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1(ETV6-RUNX1)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">B lymphoblastic leukemia/lymphoma with hyperdiploidy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">B lymphoblastic leukemia/lymphoma with hypodiploidy(Hypodiploid ALL)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1(TCF3-PBX1)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">B lymphoblastic leukemia/lymphoma, BCR-ABL1-like</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphoid leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Monoclonal B-cell lymphocytosis, CLL type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adult T-cell leukemia/lymphoma (HTLV-1 positive)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">T-cell large granular lymphocytic leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Prolymphocytic leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Prolymphocytic leukemia, B-cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Prolymphocytic leukemia, T-cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Precursor cell lymphoblastic leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Precursor T-cell lymphoblastic leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute erythroid leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloid leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chronic myeloid leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute promyelocytic leukemia, t(15;17)(q22;q11-12)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myelomonocytic leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia with inv(3)(q21;q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute basophilic leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia with abnormal marrow eosinophils</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia, minimal differentiation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia without maturation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia with maturation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chronic myelogenous leukemia, BCR/ABL positive</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical chronic myeloid leukemia, BCR/ABL negative</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia with mutated NPM1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia with biallelic mutation of CEBPA</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia with mutated RUNX1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute monocytic leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia with myelodysplasia-related changes</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia, t(8;21)(q22;q22)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia, 11q23 abnormalities</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Transient abnormal myelopoiesis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloid leukemia associated with Down syndrome</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute megakaryoblastic leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myleoid leukemia with BCR-ABL1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Therapy-related myeloid neoplasm</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloid sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute panmyelosis with myelofibrosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hairy cell leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chronic myelomonocytic leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Juvenile myelomonocytic leukemia, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Aggressive NK-cell leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Polycythemia vera</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloproliferative neoplasm, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary myelofibrosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Essential thrombocythemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chronic neutrophilic leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chronic eosinophilic leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloid or lymphoid neoplasm with PDGFRA rearrangement</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloid neoplasm with PDGFRB rearrangement</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloid or lymphoid neoplasm with FGFR1 abnormalities</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloid or lymphoid neoplasm with PCM1-JAK2</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphoproliferative disorder, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Post transplant lymphoproliferative disorder, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloproliferative neoplasm, unclassifiable</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myelodysplastic syndrome with single lineage dysplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myelodysplastic syndrome with excess blasts</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Refractory anemia with excess blasts in transformation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myelodysplastic syndrome with multilineage dysplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myelodysplastic syndrome with isolated del (5q)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Therapy-related myelodysplastic syndrome, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myelodysplastic syndrome, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Perineurioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paget's disease and intraductal carcinoma of breast</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primitive neuroectodermal tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Enteroglucagonoma, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gastrointestinal stromal tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pilocytic astrocytoma INACTIVE</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Merkel cell carcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoid tumor of uncertain malignant potential</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Meningiomatosis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neurofibromatosis, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Gastrointestinal stromal tumor, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cystic mesothelioma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, type AB, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paraganglioma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, type A, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, type B1, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, type B2, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, type B3, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiomyxoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Enterochromaffin-like cell carcinoid, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, HPV-independent, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, HPV-associated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paraganglioma of the filum terminale</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell cystadenoma of low malignant potential</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">UIHC Renomedullary interstitial cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Precursor B-cell lymphoblastic leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hemangioendothelioma, epithelioid, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pigmented dermatofibroscarcoma protuberans</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hermangiopericytoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tumorlet, NOS (inactive)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary serous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous papillary cystic tumor, borderline malignancy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous surface papillary tumor, borderline malignancy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">G-cell tumor, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Odontogenic tumor, clear cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paraganglioma, sympathetic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paraganglioma, extra-adrenal, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paraganglioma, parasympathetic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Islet cell tumor, NOS (C25._)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute myelogibrosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary serous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute lymphoblastic, I_cytic, I_oid, I_atic Leukem, L2 type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">T Cell Lymphoma*</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Langerhans cell histiocytosis, unifocal</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Langerhans cell histocyosis, multifocal</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraductal mixed with other types of carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Leukemia, T-cell lg granular lymphocytic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">B Cell Lymphoma*</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibrous histiocytoma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Dendritic cell sarcoma, not otherwise specified</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">error</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Classical Hodgkin lymphoma, nodular sclerosis Hodgkin lymphoma*</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Letterer-Siwe's disease</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphoepitheliioid lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin's disease, lymphocytic predominance, diffuse</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Peripheral T-cell lymphoma, pleomorphic medium &amp; large cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Interdigitating dendritic cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">INVASIVE DUCTAL CARCINOMA</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chronic myeloproliferative disease</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neurocytoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chronic myelomonocytic leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin's disease, lymphocytic predominance, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nodal marginal zone B-cell lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin's paragranuloma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant lymphoma, lymphcytic, poorly diff, nodular</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin's disease, nodular sclerosis, mixed cellularity</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Eosinophilic leukemia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cutaneous mastocy</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant lymphoma, lymphoblastic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant lymphoma, lymphocytic, intermidiate diff, nodular</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Refractory anemia with excess of blasts with transformation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant lumphoma, small cleaved cell, diffuse</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphomatous tumor, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Aggressive systemic masocytosis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute lymphoblastic, I_cytic, I_oid, I_atic Leukem, L1 type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Prolymphocytic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant lymphoma, centroblastic-centocytic, follicular</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant lymphoma, lymphocytic, wll diff, nodular</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Wilms tumor, favorable histology*</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant placental site trophoblastic tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiolipoma, infiltrating</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endosalpingioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiomyoliposarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelial nephroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesothelioma, biphasic type, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesenchymal nephroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibrous papule of the nose</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Warthin tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Granulosa cell-theca cell tumor, malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medullary Carcinoma, In Situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatocholangioma, benign</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in situ in familial polyposis coli</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoid tumor, argentaffin, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma in situ in multiple adenomatous polyps</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, large cell, non-keratinizing, in situ</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">5</td>
<td class="T1Head" style="padding-right: 12px;">HISTOPATHOLOGIC_TYPE_NAME</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> This column stores the name of the histopathologic type associated with the cancer stage.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">6</td>
<td class="T1Head" style="padding-right: 12px;">CANCER_TYPE_NAME</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> This column stores the name of the cancer site or type associated with the cancer stage.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">7</td>
<td class="T1Head" style="padding-right: 12px;">STAGE_SNGL_SRC_ORG_ID</td>
<td class="T1Head" style="padding-right: 12px;">NUMERIC</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> Source organization for cancer stages with a single source. </td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">8</td>
<td class="T1Head" style="padding-right: 12px;">STAGE_SNGL_SRC_ORG_ID_EXTERNAL_NAME</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> Organization's external name used as the display name on forms and user interfaces.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
</tbody></table>
<br/><br/>
<br/><br/>
</div></body></HTML>